KNOWLEDGE HUB

Insights & Intelligence

Case studies, white papers, market intelligence and clinical trends — everything you need to understand the global medical tourism landscape and China's role in it.

Cases

ChinaCureLink

17 hours ago8 min read

Cases

Case Study: Complete Remission After Combined Stem Cell Transplant and CAR-T Therapy for a Transformed Lymphoma That Had Run Out of Options

ChinaCureLink

2 days ago9 min read

Cases

Case Study: Twice-Relapsed Lymphoma, One CAR-T Infusion, and a 60-Day Watch That Ended in Remission

ChinaCureLink

3 days ago8 min read

Cases

Case Study: After Two Relapses and an Eight-Year Wait, a 70-Year-Old Foreign Patient Finally Received BCMA CAR-T Therapy for Multiple Myeloma in China

ChinaCureLink

Jul 297 min read

Cases

Case Study: China's DLBCL CAR-T Patient Achieves Complete Remission — Discharged Just 3 Weeks After Infusion

ChinaCureLink

Jul 297 min read

Cases

Case Study: Wheelchair-Bound With Bone-Wide Lymphoma, She Was Cancer-Free on PET/CT One Month After CAR-T Therapy at a Shanghai Hospital

ChinaCureLink

Jul 298 min read

Cases

Pediatric CAR-T Case Study: How a Chinese Boy Beat Leukemia With CAR-T Therapy — and Stayed Cancer-Free for 3+ Years Without a Matched Donor

ChinaCureLink

Jul 18 min read

Cases

CAR-T Treatment in China for Rare Intestinal T-Cell Lymphoma (MEITL): A Case Study

ChinaCureLink

Jun 249 min read

Cases

Relapsed T-Cell Leukemia, CD7 CAR-T Therapy, and a Second Chance in China

ChinaCureLink

Jun 2210 min read

Cases

Dual-Target CAR-T Cell Therapy for Refractory and Relapsed Burkitt Lymphoma: A Five-Year Survival Case Study in China

ChinaCureLink

Jun 1910 min read

Cases

Nine Years, One Leap: How Multiple Myeloma Led an Italian Woman to CAR-T Therapy in China

ChinaCureLink

Jun 187 min read

Cases

Refractory AML, One Last Option: How a Bone Marrow Transplant in China Brought a Young Husband Back to Life

ChinaCureLink

Jun 178 min read

Cases

Pediatric Leukemia Case: Acute Lymphoblastic Leukemia Treated with Individualized Chemotherapy in China

ChinaCureLink

Jun 1515 min read

Cases

Rare MEITL Diagnosis, No Local Targeted Therapy: How One Canadian Patient Found a Treatment Path Through China's Top Hematology Hospital - A Case Study

ChinaCureLink

Apr 248 min read

Cases

Soft Tissue Sarcoma Treatment: 56-Year-Old Southeast Asian Patient Successfully Enrolled in Clinical Trial After Remote Consultation with National Cancer Center China

ChinaCureLink

Apr 712 min read

Cases

U.S. Collaborative Second Opinion for Colon Cancer: A Malaysian Patient’s Choice to Pursue Treatment in China

ChinaCureLink

Apr 67 min read

Cases

Insights & Intelligence

Cases

Case Study: Complete Remission After Combined Stem Cell Transplant and CAR-T Therapy for a Transformed Lymphoma That Had Run Out of Options

Case Study: Twice-Relapsed Lymphoma, One CAR-T Infusion, and a 60-Day Watch That Ended in Remission

Case Study: After Two Relapses and an Eight-Year Wait, a 70-Year-Old Foreign Patient Finally Received BCMA CAR-T Therapy for Multiple Myeloma in China

Case Study: China's DLBCL CAR-T Patient Achieves Complete Remission — Discharged Just 3 Weeks After Infusion

Case Study: Wheelchair-Bound With Bone-Wide Lymphoma, She Was Cancer-Free on PET/CT One Month After CAR-T Therapy at a Shanghai Hospital

Pediatric CAR-T Case Study: How a Chinese Boy Beat Leukemia With CAR-T Therapy — and Stayed Cancer-Free for 3+ Years Without a Matched Donor

CAR-T Treatment in China for Rare Intestinal T-Cell Lymphoma (MEITL): A Case Study

Relapsed T-Cell Leukemia, CD7 CAR-T Therapy, and a Second Chance in China

Dual-Target CAR-T Cell Therapy for Refractory and Relapsed Burkitt Lymphoma: A Five-Year Survival Case Study in China

Nine Years, One Leap: How Multiple Myeloma Led an Italian Woman to CAR-T Therapy in China

Refractory AML, One Last Option: How a Bone Marrow Transplant in China Brought a Young Husband Back to Life

Pediatric Leukemia Case: Acute Lymphoblastic Leukemia Treated with Individualized Chemotherapy in China

Rare MEITL Diagnosis, No Local Targeted Therapy: How One Canadian Patient Found a Treatment Path Through China's Top Hematology Hospital - A Case Study

Soft Tissue Sarcoma Treatment: 56-Year-Old Southeast Asian Patient Successfully Enrolled in Clinical Trial After Remote Consultation with National Cancer Center China

U.S. Collaborative Second Opinion for Colon Cancer: A Malaysian Patient’s Choice to Pursue Treatment in China

How a Cholangiocarcinoma Second Opinion Led to Effective Treatment from China Top hospital for a Malaysian Patient

Stay Informed

Categories